Maksim Osipov

Also affiliated with Denali Therapeutics (United States), Sunesis (United States)

ChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial”.

Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial

Nature Communications(2025)10.1038/s41467-025-63031-y

N/A

0DataRank · unranked

11 citations

Seungyoon B. Yu, Isaac Cohen, Melania H. Fanok, Wei Luan, Romeo Maciuca +38 more